Surgical decisions made by 158 women with hereditary breast cancer aged <50 years

被引:35
|
作者
Evans, DGR
Lalloo, F
Hopwood, P
Maurice, A
Baildam, A
Brain, A
Barr, L
Howell, A
机构
[1] St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England
[2] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England
[3] S Manchester Univ Hosp Trust, Withington Hosp, Nightingale Ctr, Breast Canc Family Hist Clin, Manchester, Lancs, England
[4] Christie Hosp, Dept Psychol Med, Manchester M20 9BX, Lancs, England
[5] Christie Hosp, Dept Plast Surg, Manchester M20 9BX, Lancs, England
[6] S Manchester Univ Hosp Trust, Dept Surg, Manchester, Lancs, England
[7] Christie Hosp, Dept Med Oncol, Manchester, Lancs, England
来源
EJSO | 2005年 / 31卷 / 10期
关键词
BRCA1; BRCA2; risk-reducing mastectomy; contralateral;
D O I
10.1016/j.ejso.2005.05.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To establish the uptake of contralateral risk reducing mastectomy in women informed of their risks and options at time of diagnosis of their primary unilateral breast cancer. Methods: We have assessed the surgical choices of 70 women diagnosed with breast cancer <50 years as part of a family history surveillance program and fully informed about their contralateral. risks and surgical options. We have compared this to women from other surgical clinics who were subsequently found to harbour a pathogenic BRCA1/2 mutation. Results: Sixty-five percent (13/20) of BRCA1/2 mutation carriers and 59% (n=20/34) of those at the highest level of risk pre-diagnosis (33+% lifetime risk) opted for contra-lateral mastectomy in the study sample. In contrast only 10% (n=9/88) women identified as mutation carriers from other clinics opted for such surgery. Conclusions: We would suggest that women with a significant family history and therefore a high contra-lateral breast cancer risk, should have these risks and management options discussed at the time of diagnosis of breast cancer. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1112 / 1118
页数:7
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF BREAST CANCER SURVEILLANCE BY LIFETIME RISK IN WOMEN AGED LESS THAN 50 YEARS
    Teljeur, C.
    Harrington, P.
    Murphy, L.
    Ryan, M.
    VALUE IN HEALTH, 2013, 16 (07) : A412 - A412
  • [22] Association of depression with adherence to breast cancer screening among women aged 50 to 74 years in the United States
    Park, Chanhyun
    Ma, Xiaojing
    Park, Sun-Kyeong
    Lawson, Kenneth A.
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2020, 26 (06) : 1677 - 1688
  • [23] The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years
    Magnusson, CM
    Persson, IR
    Baron, JA
    Ekbom, A
    Bergström, R
    Adami, HO
    INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (02) : 231 - 236
  • [24] Proportion of breast cancer in women aged 50 to 69 years from Girona, Spain, according to detection method
    Puig-Vives, Montse
    Osca-Gelis, Gemma
    Camprubi-Font, Carla
    Loreto Vilardell, M.
    Izquierdo, Angel
    Marcos-Gragera, Rafael
    MEDICINA CLINICA, 2014, 143 (07): : 300 - 302
  • [25] Breast Cancer in Young Women &lt; 35 years in Kuwait: A Clinicopathological Study
    Fayaz, S.
    Eissa, H.
    Demian, G.
    Aziz, M.
    Abuzallouf, S.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S55 - S55
  • [26] Breast cancer in young women (&lt;35 years): The impact of age on the prognosis
    Bal, W.
    Jarzab, M.
    Nowara, E.
    Kowalski, M.
    Kustra, M.
    Cedrych, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Surgical decision-making in women with hereditary breast cancer risk who develop breast cancer
    Frost, Marlene H.
    Hoskin, Tanya L.
    Williams, Constance I.
    Alters, Teresa M.
    Degnim, Amy C.
    Hartmann, Lynn C.
    Boughey, Judy C.
    QUALITY OF LIFE RESEARCH, 2012, 21 : 123 - 123
  • [28] Microdochectomy in women aged over 50 years
    Burton, S
    Li, WY
    Himpson, R
    Sulieman, S
    Ball, A
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2003, 85 (01) : 47 - 49
  • [29] Invasive breast cancer in women aged 35 and under: surgical treatment
    Fancellu, A.
    Cottu, P.
    Feo, C. F.
    Scanu, A. M.
    Giuliani, G.
    EJC SUPPLEMENTS, 2004, 2 (03): : 163 - 163
  • [30] Surgical treatment of hereditary breast cancer
    Chiappa, C.
    Fachinetti, A.
    Dionigi, G.
    Rovera, F.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S104 - S104